Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06586307
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-02
Brief Title:
Estimating Lymphocyte Counts from DNA Methylation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Assessment of DNA Methylation Signatures in Lymphocytes for Evaluating the Efficacy and Prognosis of Immunotherapy in Colorectal Cancer
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to assess lymphocyte levels in colorectal cancer patients using DNA methylation levels in tissues or blood The main questions it aims to answer are
Can DNA methylation features calculate lymphocyte levels Can the calculated lymphocyte levels assess the efficacy and prognosis of immunotherapy
Can DNA methylation features calculate lymphocyte levels Can the calculated lymphocyte levels assess the efficacy and prognosis of immunotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None